This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Relman¹ felt that it is inappropriate for industry to support continuing medical education (CME) while Mr Holmer² felt that such support is constructive. I wonder if Relman and others who have written against such support have considered the inherent intelligence of the physicians and their rigorous scientific and clinical training that allow them to make appropriate judgments of industry-supported CME. To think otherwise would denigrate most physicians. I wonder if there are studies to show that physicians change their attitudes based on industry-supported CME that is not validated by appropriate research.

I would also add my personal experience as a lecturer on atrial fibrillation, dyslipidemias, and hypertension for 2 major pharmaceutical companies. The sponsors have never asked or advised me about the content of my presentations. And, as an attendee of such CME activities, rarely if ever, have I heard the lecturer refer to the products . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Separating Continuing Medical Education From Pharmaceutical Marketing
Arnold S. Relman
JAMA. 2001;285(15):2009-2012.
EXTRACT | FULL TEXT